Laekna Inc Sustainability Reports
Laekna, Inc. is a clinical-stage biotechnology company focused on the discovery and development of innovative small-molecule and antibody therapies. The company targets unmet medical needs in oncology, metabolic diseases, obesity, and liver fibrosis.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01H2TK2H0
4 reports from 2023 to 2025
